IntriCon Corporation (IIN)
NASDAQ: IIN
· Real-Time Price · USD
24.23
0.03 (0.12%)
At close: Apr 24, 2025, 3:47 PM
IntriCon Revenue Breakdown
| Period Ending | Dec 31, 2020 | Dec 31, 2019 |
|---|---|---|
| Hearing Health Direct To Consumer Dtc Market Revenue | 917K | 1.24M |
| Hearing Health Direct To Consumer Dtc Market Revenue Growth | -26.29% | n/a |
| Hearing Health Value Based Itec Revenue | 1.67M | 1.49M |
| Hearing Health Value Based Itec Revenue Growth | +12.01% | n/a |
| Legacy Oem Revenue | 2.52M | 2.14M |
| Legacy Oem Revenue Growth | +17.78% | n/a |
| Medical Biotelemetry Diabetes Revenue | 17.74M | 17.77M |
| Medical Biotelemetry Diabetes Revenue Growth | -0.15% | n/a |
| Medical Biotelemetry Other Revenue | 6.17M | 3.54M |
| Medical Biotelemetry Other Revenue Growth | +74.29% | n/a |
| Professional Audio Communications Revenue | 1.28M | 1.51M |
| Professional Audio Communications Revenue Growth | -15.14% | n/a |
Revenue by Geography
| Period Ending | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Sep 30, 2013 | Jun 30, 2013 | Mar 31, 2013 | Dec 31, 2012 | Sep 30, 2012 | Jun 30, 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| All Other Countries Revenue | 5.03M | 3.82M | 3.29M | 2.72M | 3.33M | 3.81M | 3.71M | 2.63M | 328K | 3.23M | 382K | 188K | 182K | 354K | 437K | 322K | 552K | 749K | 870K | 406K | 828K | 377K |
| All Other Countries Revenue Growth | +31.78% | +15.97% | +21.06% | -18.41% | -12.40% | +2.61% | +41.33% | +700.30% | -89.83% | +744.24% | +103.19% | +3.30% | -48.59% | -18.99% | +35.71% | -41.67% | -26.30% | -13.91% | +114.29% | -50.97% | +119.63% | n/a |
| Asia Revenue | 2.04M | 2.48M | 2.58M | 4.02M | 3.47M | 2.89M | 3.6M | 2.79M | 2.2M | -134K | 2.78M | 3.22M | 3.51M | 2.37M | 2.47M | 2.7M | n/a | n/a | n/a | n/a | n/a | n/a |
| Asia Revenue Growth | -17.83% | -3.83% | -35.67% | +15.83% | +20.00% | -19.61% | +28.81% | +26.86% | -1741.79% | -104.82% | -13.64% | -8.26% | +48.06% | -4.13% | -8.41% | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Europe Revenue | 1.96M | 1.98M | 1.64M | 1.68M | 1.26M | 1.43M | 1.93M | 957K | 1.19M | 1.13M | 1.25M | 1.57M | 2.2M | 2.13M | 2.07M | 1.88M | n/a | n/a | n/a | n/a | n/a | n/a |
| Europe Revenue Growth | -1.01% | +21.06% | -2.27% | +32.59% | -11.67% | -25.70% | +101.25% | -19.38% | +4.95% | -9.38% | -20.41% | -28.82% | +3.43% | +3.00% | +9.77% | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| United States Revenue | 24.02M | 23.89M | 23.53M | 21.8M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| United States Revenue Growth | +0.57% | +1.49% | +7.95% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 6.63M | 6.81M | 5.99M | 6.09M | 6.03M | 4.97M | 5.02M | 6.28M | 5.41M | 5.81M | 6.32M | 6.72M | 6.96M | 7.21M | 6.24M | 5.99M | 5.9M | 4.97M | 5.04M | 4.91M | 4.87M | 3.73M | 3.33M | 3.31M | 3.49M | 3.13M | 2.56M | 2.63M | 2.7M |
| Selling, General, and Administrative Revenue Growth | -2.69% | +13.69% | -1.64% | +0.94% | +21.48% | -1.04% | -20.12% | +16.16% | -6.89% | -8.14% | -5.92% | -3.43% | -3.52% | +15.61% | +4.21% | +1.49% | +18.78% | -1.43% | +2.67% | +0.82% | +30.64% | +11.85% | +0.73% | -5.13% | +11.26% | +22.33% | -2.62% | -2.41% | n/a |
| Research and Development Revenue | 1.59M | 1.54M | 1.17M | 1.31M | 1.29M | 1.38M | 1.46M | 1.21M | 1.2M | 928K | 840K | 1.1M | 965K | 978K | 1.25M | 1.32M | 1.16M | 1.15M | 1.05M | 1.11M | 1.15M | 391K | 1.32M | 1.56M | 1.42M | 1.35M | 1.34M | 1.29M | 1.23M |
| Research and Development Revenue Growth | +3.05% | +31.29% | -10.39% | +1.24% | -6.30% | -5.35% | +20.60% | +0.67% | +29.42% | +10.48% | -23.43% | +13.68% | -1.33% | -21.82% | -4.94% | +13.55% | +1.13% | +9.46% | -5.85% | -3.56% | +194.88% | -70.45% | -15.08% | +10.03% | +4.89% | +0.45% | +3.86% | +5.55% | n/a |
| Sales and Marketing Revenue | 2.32M | 2.22M | 2.05M | 2.02M | 1.98M | 1.63M | 1.36M | 1.68M | 1.99M | 2.43M | 2.61M | 3.07M | 3.54M | 3.64M | 3.01M | 2.88M | 2.84M | 2.59M | 2.34M | 2.2M | 2.31M | 1.22M | 1.08M | 1.2M | 1.2M | 1.18M | 854K | 898K | 987K |
| Sales and Marketing Revenue Growth | +4.23% | +8.59% | +1.34% | +1.97% | +21.37% | +19.63% | -18.75% | -15.70% | -17.88% | -6.98% | -15.07% | -13.12% | -2.86% | +20.97% | +4.44% | +1.44% | +9.65% | +10.59% | +6.26% | -4.63% | +89.12% | +12.94% | -9.83% | +0.33% | +1.36% | +38.17% | -4.90% | -9.02% | n/a |